[ESG 점검] 삼성바이오, 단체교섭 리스크 현실화…내년 S지표 시험대

Samsung BioLogistics' first labor strike and dispute directly threaten next year's ESG report's social metrics, exposing the fundamental tension between protecting collective bargaining rights and ensuring supply chain continuity. As the company operates under a pure CDMO model where production stoppages directly impact customer contracts, managing labor relations becomes a critical ESG disclosure challenge with significant implications for investor confidence. The company must now demonstrate effective conflict resolution capability under real business pressure, shifting the narrative from simply reporting stable labor relations to proving resilient human rights management.